Journals / Medicine Science / 2022 / Cilt: 11 - Sayı: 1

Evaluation of the effect of obesity on fibromyalgia in premenopausal female patients

Pages
387–393
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, prevention and medical treatment of obesity, can positively affect many parameters in the body and reduce the incidence of FMS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity is a chronic disease whose prevalence is increasing all over the world.
📊
Key Findings & Data:Anamnesis, physical examination and laboratory data obtained from 103 female patients who were divided into two groups as obese and non-obese according to body mass index (BMI) were statistically analyzed in terms of FMS. 25.2% of the women participating in the study were diagnosed with FMS, and the mean age of the cases was 33.42 (± 10.41), the mean weight was 79.65 (± 19.91), and the mean BMI was 30.52 (± 7.75).
💡
Conclusion & Impact:Therefore, prevention and medical treatment of obesity, can positively affect many parameters in the body and reduce the incidence of FMS.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obesity is a chronic disease whose prevalence is increasing all over the world. The relationship between obesity and some rheumatic diseases such as Fibromyalgia Syndrome (FMS) has recently attracted attention. In this study, we investigated the effect of obesity on FMS in premenopausal female patients. Anamnesis, physical examination and laboratory data obtained from 103 female patients who were divided into two groups as obese and non-obese according to body mass index (BMI) were statistically analyzed in terms of FMS. 25.2% of the women participating in the study were diagnosed with FMS, and the mean age of the cases was 33.42 (± 10.41), the mean weight was 79.65 (± 19.91), and the mean BMI was 30.52 (± 7.75). The mean age of the obese was higher 38.48 (± 8.95) and the incidence of obesity was significantly higher with age (p ˂ 0.001). The frequency of FMS (p = 0.001), Fibromyalgia Impact Questionnaire results (p = 0.001) and tender point numbers in the Widespread Pain Index Scale (p ˂ 0.001) were significantly higher in the obese group. There was no statistically significant difference between the obese and non-obese groups in terms of marital status, occupation, smoking history and education levels. Obesity prevalence is increasing all over the world and the results of the present study reveal FMS complications are getting worse by obesity. Therefore, prevention and medical treatment of obesity, can positively affect many parameters in the body and reduce the incidence of FMS.

🔖

Cite This Article

GÜRLER, M., OĞUZ, D. A. (2022). Evaluation of the effect of obesity on fibromyalgia in premenopausal female patients. Medicine Science, Cilt: 11 - Sayı: 1, 387–393. https://ajindex.com/articles/579525

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Tchang BG, Saunders KH, Igel LI. Best practices in the management of overweight and obesity. Med Clin North Am. 2021;105:149–74
  2. D’Onghia M, Ciaffi J, Lisi L, et al. Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51:409–24
  3. Rodríguez-Roca B, Urcola-Pardo F, Anguas-Gracia A, et al. Impact of reducing sitting time in women with fibromyalgia and obesity: a randomized controlled trial. Int J Environ Res Public Health. 2021;18
  4. Singh JA, Saag KG, Bridges SL, et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68:1–26
  5. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000;20:9–12
  6. Zheng H, Chen C. Body mass index and risk of knee osteoarthritis: systematic review and meta-analysis of prospective studies. BMJ Open. 2015 1;5:e007568
  7. Mansoor S, Siddiqui M, Mateen F, et al. Prevalence of obesity in carpal tunnel syndrome patients: a cross-sectional survey. Cureus. 2017;26;9
  8. Zhang TT, Liu Z, Liu YL, et al. Obesity as a risk factor for low back pain. Clin Spine Surg. 2018;31:22–7
  9. Arreghini M, Manzoni GM, Castelnuovo G, et al. Impact of fibromyalgia on functioning in obese patients undergoing comprehensive rehabilitation. PLoS ONE. 2014;9:91392
  10. Arnold LM, Clauw DJ. Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Postgrad Mede. 2017;129:709–14
  11. Topbas M, Cakirbay H, Gulec H, et al. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol. 2005;34:140–4
  12. Cakirbay H, Cebi A, Cebi E, et al. Risk factors of fibromyalgia in Turkish women. Pain Clin. 2006 5;18:251–7
  13. Saber AA, Boros MJ, Mancl T, et al. The effect of laparoscopic roux-en-y gastric bypass on fibromyalgia. Obes Surg. 2008;18:652–5
  14. Gota CE, Kaouk S, Wilke WS. Fibromyalgia and obesity: The association between body mass index and disability, depression, history of abuse, medications, and comorbidities. J Clin Rheumatol. 2015;21:289–95 15. Bennett RM, Jones J, Turk DC, et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disord. 2007;8:1–11
  15. Neumann L, Lerner E, Glazer Y, et al. A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgi